Showing results (31-40 of 1,983) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|April 25, 2017
Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort studyJosé M A Wijnands, Elaine Kingwell, Feng Zhu, et al.The Lancet. Neurology|August 19, 2011
Neuroschistosomiasis: clinical symptoms and pathogenesisTeresa Cristina A Ferrari, Paulo Roberto R MoreiraThe Lancet. Neurology|December 14, 2011
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyIlse Gijselinck, Tim Van Langenhove, Julie van der Zee, et al.The Lancet. Neurology|October 1, 2011
Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudyLenore J Launer, Michael E Miller, Jeff D Williamson, et al.The Lancet. Neurology|April 21, 2012
Childhood spinal muscular atrophy: controversies and challengesEugenio Mercuri, Enrico Bertini, Susan T IannacconeThe Lancet. Neurology|December 17, 2011
Migraine and stroke: a complex association with clinical implicationsTobias Kurth, Hugues Chabriat, Marie-Germaine BousserThe Lancet. Neurology|December 17, 2011
Complications of intracerebral haemorrhageJoyce S Balami, Alastair M BuchanThe Lancet. Neurology|December 8, 2011
Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trialGiancarlo Comi, Nicola De Stefano, Mark S Freedman, et al.The Lancet. Neurology|March 24, 2012
Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translationDirk M Hermann, Michael ChoppThe Lancet. Neurology|April 23, 2011
The pharmacological treatment of epilepsy in adultsEmilio Perucca, Torbjörn TomsonPageof 199